Kerala Ayurveda Ltd. benchmarking: Performance to industry peers

Financial

	Kerala Ayurveda	Ambalal Sarabhai Ent	Lyka Labs
Operational Metrics
Financials
5 yr Average ROE	7.73 %	19.11 %	68.98 %
5yr average Equity Multiplier	17.91	2.07	2.9
5yr Average Asset Turnover Ratio	0.77	0.75	0.73
5yr Avg Net Profit Margin	-3.82 %	10.89 %	-0.79 %
Price to Book	21.85	1.52	2.71
P/E	0.0	13.56	0.0
5yr Avg Cash Conversion Cycle	-36.58 Days	-37.53 Days	32.55 Days
Inventory Days	51.76 Days	33.51 Days	24.2 Days
Days Receivable	51.0 Days	63.69 Days	92.33 Days
Days Payable	164.59 Days	147.98 Days	106.74 Days
5yr Average Interest Coverage Ratio	0.36	9.88	2.2
5yr Avg ROCE	0.83 %	24.01 %	25.83 %
5yr Avg Operating Profit Margin	3.63 %	5.29 %	24.02 %
5 yr average Debt to Equity	11.28	0.32	1.25
5yr CAGR Net Profit	24.88 %	-30.01 %	n/a
5yr Average Return on Assets	-3.11 %	8.69 %	1.72 %
Shareholdings
Promoter Holding	35.61 %	31.36 %	58.16 %
Share Pledged by Promoters	20.35 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-25.91 %	0.59 %	7.16 %
Change in Mutual Fund Holding (3 Yrs)	-0.01 %	0.0	-3.3 %

	Kerala Ayurveda	Ambalal Sarabhai Ent	Lyka Labs
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals 100.0 Electronics 0 Formulations 0 Bulk Drugs 0	Product Wise Break-Up Formulations 0 Electronics 53.67 Pharmaceutical 46.33 Bulk Drugs 0	Product Wise Break-Up Formulations 96.8 Electronics 0 Pharmaceuticals 0 Bulk Drugs 3.2